close
Add to watchlist
MiddleBrook Pharmaceuticals Inc (MBRK)
MiddleBrook Pharmaceuticals, Inc., a pharmaceutical company, engages in the development and commercialization of anti-infective drug products in the United States. The company develops a proprietary delivery technology called PULSYS, which enables the pulsatile delivery, or delivery in rapid bursts, of drugs. Its product portfolio includes MOXATAG tablets for the treatment of pharyngitis and tonsillitis; and KEFLEX capsules for the treatment of skin and skin structure infections and upper respiratory tract infections. MiddleBrook Pharmaceuticals sells its products through specialty pharmaceutical distributors and wholesalers to physicians, hospitals, and pharmacies. The company was formerly known as Advancis Pharmaceutical Corporation and changed its name to MiddleBrook Pharmaceuticals, Inc. in June 2007. MiddleBrook Pharmaceuticals was founded in 1999 and is headquartered in Germantown, Maryland.
(login to add this stock to your watchlist or favorites)
Key Statistics
| Closing Price | 0.13 |
| Volume | (mio) 9.05 |
| Volume Avg | (mio) 1.05 |
| 52 Week High | 1.97 |
| 52 Week Low | 0.08 |
| PE | N/A |
| PE (group average) | N/A |
| EPS Year | -0.72 |
| EPS change Q/Q | -13.04% |
| EPS change Q/Q Yr ago | -5.26% |
| EPS change Q/Q next Q est | 100% |
| EPS change Y/Y | -4.41% |
| REV change Q/Q | -47.62% |
| REV change Q/Q Yr ago | -52.17% |
| EPS next Q est | 0.00 |
| EPS next Y est | 0.00 |
| Divident Annual | 0.00 |
| Dividend Yield | 0% |